Section 12-280-402 - DefinitionsAs used in this part 4, unless the context otherwise requires:
(1) "Controlled substance" means any schedule II, III, IV, or V drug as listed in sections 18-18-204, 18-18-205, 18-18-206, and 18-18-207.(2) "Drug abuse" or "abuse" means utilization of a controlled substance for nonmedical purposes or in a manner that does not meet generally accepted standards of medical practice.(2.3) "Hospital" means a hospital licensed or certified pursuant to section 25-1.5-103.(2.5) "Medical director" means a medical director or nurse medical director of a medical practice or hospital in this state who is a "prescriber" as defined in section 12-30-111 (4).(3) "Prescription drug outlet" or "pharmacy" means:(a) Any resident or nonresident pharmacy outlet registered or licensed pursuant to this article 280 where prescriptions are compounded and dispensed;(b) Any federally owned and operated pharmacy registered with the federal drug enforcement administration; and(c) A telepharmacy outlet.(4) "Program" means the electronic prescription drug monitoring program developed or procured by the board in accordance with section 12-280-403.Amended by 2024 Ch. 440,§ 2, eff. 6/6/2024.Amended by 2022 Ch. 484, § 4, eff. 8/10/2022.Renumbered from C.R.S. § 12-42.5-402 and amended by 2019 Ch. 136, § 1, eff. 10/1/2019.Amended by 2014 Ch. 239, § 1, eff. 5/21/2014.L. 2012: Entire article added with relocations, (HB 12-1311), ch. 281, p. 1590, § 1, effective July 1. L. 2014: (1) and (4) amended and (1.5) added, (HB 14-1283), ch. 239, p. 882, § 1, effective May 21.This section is similar to former § 12-42.5-402 as it existed prior to 2019.
2022 Ch. 484, was passed without a safety clause. See Colo. Const. art. V, § 1(3).